Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.

Clinical trials sponsored by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd., explained in plain language.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 603707 SSE

A Chinese pharmaceutical company focused on biochemical drugs, including heparin products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

Can a new biosimilar match Neulasta's power to rebuild white blood cells?

Disease control Recruiting now

This trial is testing whether an experimental drug called NKF-PEG works in the same way as the approved medicine Neulasta. Both are designed to help the body produce more white blood cells, which are important for fighting infection. Healthy adult male volunteers will receive a s…

Phase: PHASE1 • Sponsor: Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC